HIGHLIGHTS
- who: Sphingolipid Metabolism New Insight and colleagues from the DiderotInstitut Hospitalo-Universitaire ICAN, France have published the research work: Molecular Sciences, in the Journal: (JOURNAL)
- what: The study showed quite similar results by directly adding short-chain C2-ceramides to the cells .
- how: This review describes the latest progress involving ceramides as major players in the development of muscle insulin-resistance through the targeting of selective actors of the insulin signaling pathway. The authors of this paper showed that C18-ceramides played a very important role in fat storage by inhibiting mitochondrial β-oxidation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.